502 related articles for article (PubMed ID: 34386008)
1. Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis.
Tu L; Lin C; Xie Y; Wang X; Wei Q; Zhang Y; Gu J
Front Immunol; 2021; 12():700260. PubMed ID: 34386008
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
[TBL] [Abstract][Full Text] [Related]
3. MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation.
Maksymowych WP; Wichuk S; Dougados M; Jones H; Szumski A; Bukowski JF; Marshall L; Lambert RG
Arthritis Res Ther; 2017 Jun; 19(1):126. PubMed ID: 28587658
[TBL] [Abstract][Full Text] [Related]
4. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
[TBL] [Abstract][Full Text] [Related]
5. MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis.
Lu CC; Huang GS; Lee TS; Chao E; Chen HC; Guo YS; Chu SJ; Liu FC; Kao SY; Hou TY; Chen CH; Chang DM; Lyu SY
J Transl Med; 2021 Jul; 19(1):298. PubMed ID: 34243762
[TBL] [Abstract][Full Text] [Related]
6. MR distribution of active inflammatory and chronic structural sacroiliac joint changes in axial spondyloarthropathy: Challenging conventional wisdom.
Motamedi D; Patel R; Devulapalli KK; Gensler LS; Steinbach L
Clin Imaging; 2019; 58():70-73. PubMed ID: 31252214
[TBL] [Abstract][Full Text] [Related]
7. Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP; Baraliakos X; Lambert RG; Landewé R; Sandoval D; Carlier H; Lisse J; Li X; Hojnik M; Østergaard M
Lancet Rheumatol; 2022 Sep; 4(9):e626-e634. PubMed ID: 38288892
[TBL] [Abstract][Full Text] [Related]
8. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
Kang KY; Jung JY; Hong YS; Ju JH; Park SH
Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
[TBL] [Abstract][Full Text] [Related]
9. Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP; Wichuk S; Dougados M; Jones HE; Pedersen R; Szumski A; Marshall L; Bukowski JF; Lambert RG
Ann Rheum Dis; 2018 Jan; 77(1):78-84. PubMed ID: 28970212
[TBL] [Abstract][Full Text] [Related]
10. Non-radiographic axial spondyloarthritis in South America. Burden of disease and differential features with respect to ankylosing spondylitis at time of diagnosis. A comprehensive analysis with a focus on images.
Garcia Salinas R; Jaldin Cespedes R; Gomez RA; Aguerre D; Sommerfleck F
Int J Rheum Dis; 2022 Oct; 25(10):1169-1175. PubMed ID: 35891615
[TBL] [Abstract][Full Text] [Related]
11. Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.
van der Heijde D; Baraliakos X; Hermann KA; Landewé RBM; Machado PM; Maksymowych WP; Davies OR; de Peyrecave N; Hoepken B; Bauer L; Nurminen T; Braun J
Ann Rheum Dis; 2018 May; 77(5):699-705. PubMed ID: 29343510
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of 3 Preliminary MRI Sacroiliac Joint Composite Structural Damage Scores in a 5-year Longitudinal Axial Spondyloarthritis Study.
Wetterslev M; Østergaard M; Sørensen IJ; Weber U; Loft AG; Kollerup G; Juul L; Thamsborg G; Madsen OR; Møller JM; Pedersen SJ
J Rheumatol; 2021 Oct; 48(10):1537-1546. PubMed ID: 33858979
[TBL] [Abstract][Full Text] [Related]
13. Morphological characteristics of sacroiliac joint MRI lesions in axial spondyloarthritis and control subjects.
Seven S; Østergaard M; Morsel-Carlsen L; Sørensen IJ; Bonde B; Thamsborg G; Lykkegaard JJ; Pedersen SJ
Rheumatology (Oxford); 2022 Mar; 61(3):1005-1017. PubMed ID: 34097000
[TBL] [Abstract][Full Text] [Related]
14. Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI.
Althoff CE; Sieper J; Song IH; Haibel H; Weiß A; Diekhoff T; Rudwaleit M; Freundlich B; Hamm B; Hermann KG
Ann Rheum Dis; 2013 Jun; 72(6):967-73. PubMed ID: 22736088
[TBL] [Abstract][Full Text] [Related]
15. The influence of age on the prevalence of inflammatory and structural MRI lesions in the sacroiliac joints of patients with and without axial spondyloarthritis.
Baraliakos X; Kuehn A; Tsiami S; Kiltz U; Fruth M; Braun J
Rheumatology (Oxford); 2023 Apr; 62(4):1519-1525. PubMed ID: 36083015
[TBL] [Abstract][Full Text] [Related]
16. Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: prevalence of lesions and association with clinical and disease activity indices from the Italian group of the SPACE study.
Lorenzin M; Ortolan A; Frallonardo P; Vio S; Lacognata C; Oliviero F; Punzi L; Ramonda R
Reumatismo; 2016 Sep; 68(2):72-82. PubMed ID: 27608795
[TBL] [Abstract][Full Text] [Related]
17. Baseline Severity of Sacroiliitis and Extensive Fat Metaplasia Predicts the Progression of Backfill at the Sacroiliac Joint in Patients With Axial Spondyloarthritis.
Zhang Y; Guo Z; Wang L; Zhan Y; Qu J; Lei X
Front Immunol; 2022; 13():887470. PubMed ID: 35833133
[TBL] [Abstract][Full Text] [Related]
18. Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis.
Braun J; Blanco R; Marzo-Ortega H; Gensler LS; Van den Bosch F; Hall S; Kameda H; Poddubnyy D; van de Sande M; van der Heijde D; Zhuang T; Stefanska A; Readie A; Richards HB; Deodhar A
Arthritis Res Ther; 2023 May; 25(1):80. PubMed ID: 37194094
[TBL] [Abstract][Full Text] [Related]
19. MRI compared with low-dose CT scanning in the diagnosis of axial spondyloarthritis.
Ye L; Liu Y; Xiao Q; Dong L; Wen C; Zhang Z; Jin M; Brown MA; Chen D
Clin Rheumatol; 2020 Apr; 39(4):1295-1303. PubMed ID: 31797168
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis.
Pedersen SJ; Wichuk S; Chiowchanwisawakit P; Lambert RG; Maksymowych WP
Arthritis Res Ther; 2014 Apr; 16(2):R100. PubMed ID: 24755322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
